ArticleExpert opinion on therapeutic patents2017

Reply to 'Highly selective A3 adenosine receptor agonists relieve chronic neuropathic pain'.

Rodolfo Couto MaiaPubMed ↗Publisher ↗

No numbers read from the abstract.